Updated safety data of AEGEAN study

Dr László Urbán, pulmonologist from the Matrahaza University and Teaching Hospital, Matrahaza, Hungary presents updated safety data with ∼9 months additional study follow-up of the AEGEAN trial with perioperative durvalumab and neoadjuvant chemotherapy for resectable NSCLC patients.